SanBio, Feb-Apr (1Q) Net Income Loss Widens

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Jun 13, 2025 3:30 pm JST Earnings

4592 SanBio Company Limited 【J-GAAP】

Earnings Report

SanBio Company Limited <4592> [TSE Growth] announced its financial results after the market closed on June 13th (15:30). The consolidated net loss for the first quarter of the fiscal year ending January 2026 (February to April) expanded to a loss of 1.53 billion yen (compared to a loss of 0.14 billion yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Feb - Apr, 2023	0	-1,461	-937	-626	-9.7	ー	Jun 14, 2023	J-GAAP
Feb - Apr, 2024	0	-666	91	-144	-2.1	ー	Jun 13, 2024	J-GAAP
Feb - Apr, 2025	0	-1,007	-1,750	-1,531	-21.4	ー	Jun 13, 2025	J-GAAP
YoY	－	-51.2%	－	-963.2%	-908.5%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb - Jul, 2024	0	-1,571	-1,186	-1,309	-19.1	0	Sep 17, 2024	J-GAAP
Feb - Jul, 2025 Guidance	ー	-1,911	-1,943	-1,943	-27.0	0	Mar 17, 2025	J-GAAP
YoY	－	-21.6%	-63.8%	-48.4%	-41.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan, 2024	0	-4,539	-2,824	-2,644	-40.5	0	Mar 18, 2024	J-GAAP
Jan, 2025	0	-3,516	-3,022	-2,882	-41.9	0	Mar 17, 2025	J-GAAP
Jan, 2026 Guidance	ー	-3,509	-3,551	-3,554	-45.6	0	Mar 17, 2025	J-GAAP
YoY	－	+0.2%	-17.5%	-23.3%	-8.8%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Feb - Apr, 2024	0	-666	91	-144	-2.1	-Inf	Jun 13, 2024	J-GAAP
May - Jul, 2024	0	-905	-1,277	-1,165	-17.0	-Inf	Sep 17, 2024	J-GAAP
Aug - Oct, 2024	0	-911	-813	-843	-12.3	-Inf	Dec 16, 2024	J-GAAP
Nov - Jan, 2024	0	-1,034	-1,023	-730	-10.6	-Inf	Mar 17, 2025	J-GAAP
Feb - Apr, 2025	0	-1,007	-1,750	-1,531	-21.4	-Inf	Jun 13, 2025	J-GAAP
YoY	－	-51.2%	－	-963.2%	-908.5%